Townsend & Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-17,152
| Closed | -$1.32M | – | 112 |
|
|
2023
Q2 | $1.32M | Sell |
17,152
-1,669
| -9% | -$129K | 0.34% | 66 |
|
|
2023
Q1 | $1.55M | Sell |
18,821
-11,288
| -37% | -$928K | 0.62% | 60 |
|
|
2022
Q4 | $2.63M | Sell |
30,109
-405
| -1% | -$35.4K | 1.3% | 28 |
|
|
2022
Q3 | $2.51M | Buy |
30,514
+1,497
| +5% | +$123K | 1.16% | 25 |
|
|
2022
Q2 | $1.82M | Buy |
29,017
+2,250
| +8% | +$141K | 0.84% | 40 |
|
|
2022
Q1 | $1.67M | Buy |
26,767
+2,774
| +12% | +$173K | 0.77% | 52 |
|
|
2021
Q4 | $1.72M | Buy |
+23,993
| New | +$1.72M | 0.94% | 46 |
|